These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 35894764)

  • 1. Long-term events following catheter-ablation for atrial fibrillation in heart failure with preserved ejection fraction.
    Ishiguchi H; Yoshiga Y; Shimizu A; Ueyama T; Fukuda M; Kato T; Fujii S; Hisaoka M; Uchida T; Omuro T; Okamura T; Kobayashi S; Yano M
    ESC Heart Fail; 2022 Oct; 9(5):3505-3518. PubMed ID: 35894764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction.
    Black-Maier E; Ren X; Steinberg BA; Green CL; Barnett AS; Rosa NS; Al-Khatib SM; Atwater BD; Daubert JP; Frazier-Mills C; Grant AO; Hegland DD; Jackson KP; Jackson LR; Koontz JI; Lewis RK; Sun AY; Thomas KL; Bahnson TD; Piccini JP
    Heart Rhythm; 2018 May; 15(5):651-657. PubMed ID: 29222043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction.
    Machino-Ohtsuka T; Seo Y; Ishizu T; Sugano A; Atsumi A; Yamamoto M; Kawamura R; Machino T; Kuroki K; Yamasaki H; Igarashi M; Sekiguchi Y; Aonuma K
    J Am Coll Cardiol; 2013 Nov; 62(20):1857-65. PubMed ID: 23916940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial Fibrillation Ablation in Heart Failure With Reduced vs Preserved Ejection Fraction: A Systematic Review and Meta-Analysis.
    Oraii A; McIntyre WF; Parkash R; Kowalik K; Razeghi G; Benz AP; Belley-Côté EP; Conen D; Connolly SJ; Tang ASL; Healey JS; Wong JA
    JAMA Cardiol; 2024 Jun; 9(6):545-555. PubMed ID: 38656292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter ablation of atrial fibrillation reduces heart failure rehospitalization in patients with heart failure with preserved ejection fraction.
    Fukui A; Tanino T; Yamaguchi T; Hirota K; Saito S; Okada N; Akioka H; Shinohara T; Yufu K; Takahashi N
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):682-688. PubMed ID: 31985099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risks of Heart Failure, Stroke, and Bleeding in Atrial Fibrillation According to Heart Failure Phenotypes.
    Inciardi RM; Giugliano RP; Park JG; Nordio F; Ruff CT; Chen C; Lanz HJ; Antman EM; Braunwald E; Solomon SD
    JACC Clin Electrophysiol; 2023 Apr; 9(4):569-580. PubMed ID: 37100536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catheter ablation for patients with atrial fibrillation and heart failure: insights from the Swedish Heart Failure Registry.
    von Olshausen G; Benson L; Dahlström U; Lund LH; Savarese G; Braunschweig F
    Eur J Heart Fail; 2022 Sep; 24(9):1636-1646. PubMed ID: 35779270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Outcomes After Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Versus Reduced Ejection Fraction.
    Aldaas OM; Malladi CL; Mylavarapu PS; Lupercio F; Darden D; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Feld GK; Hsu JC
    Am J Cardiol; 2020 Dec; 136():62-70. PubMed ID: 32941815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atrial resynchronization therapy in patients with atrial fibrillation and heart failure with and without systolic left ventricular dysfunction: a pilot study.
    Saksena S; Slee A; Saad M
    J Interv Card Electrophysiol; 2018 Oct; 53(1):9-17. PubMed ID: 29987682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of catheter ablation of atrial fibrillation on long-term clinical outcomes in patients with heart failure.
    Ichijo S; Miyazaki S; Kusa S; Nakamura H; Hachiya H; Kajiyama T; Iesaka Y
    J Cardiol; 2018 Sep; 72(3):240-246. PubMed ID: 29609877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure and Preserved Ejection Fraction.
    Zylla MM; Leiner J; Rahm AK; Hoffmann T; Lugenbiel P; Schweizer P; Scholz E; Mereles D; Kronsteiner D; Kieser M; Katus HA; Frey N; Thomas D
    Circ Heart Fail; 2022 Sep; 15(9):e009281. PubMed ID: 36126143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Catheter ablation for non-paroxysmal atrial fibrillation accompanied by heart failure with preserved ejection fraction: feasibility and benefits in functions and B-type natriuretic peptide.
    Yamauchi R; Morishima I; Okumura K; Kanzaki Y; Morita Y; Takagi K; Nagai H; Watanabe N; Furui K; Yoshioka N; Miyazawa H; Shimojo K; Imaoka T; Sakamoto G; Murohara T
    Europace; 2021 Aug; 23(8):1252-1261. PubMed ID: 33693617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial Fibrillation can adversely impact Heart Failure with Preserved Ejection Fraction by its association with Heart Failure Progression and Mortality: A Post-Hoc Propensity Score-Matched Analysis of the TOPCAT Americas Trial.
    Saksena S; Slee A; Natale A; Lakkireddy DR; Shah D; Di Biase L; Lewalter T; Nagarakanti R; Santangeli P
    Europace; 2023 May; 25(5):. PubMed ID: 37078691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation for patients with atrial fibrillation and heart failure with reduced and preserved ejection fraction: insights from the KiCS-AF multicentre cohort study.
    Shiraishi Y; Kohsaka S; Ikemura N; Kimura T; Katsumata Y; Tanimoto K; Suzuki M; Ueda I; Fukuda K; Takatsuki S
    Europace; 2023 Feb; 25(1):83-91. PubMed ID: 35851807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of incident atrial fibrillation in heart failure with preserved or reduced ejection fraction: A community-based study.
    Zhang P; Chamberlain AM; Hodge DO; Cai C; Xiao PL; Han J; Jiang CY; Redfield MM; Roger VL; Cha YM
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2275-2283. PubMed ID: 32584498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoballoon ablation for atrial fibrillation in patients with heart failure with mildly reduced and preserved ejection fraction.
    Chen C; Cheng K; Gao X; Zou T; Pang Y; Ling Y; Xu Y; Xu Y; Chen Q; Zhu W; Ge J
    ESC Heart Fail; 2023 Feb; 10(1):518-531. PubMed ID: 36325978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure progression and mortality in atrial fibrillation patients with preserved or reduced left ventricular ejection fraction.
    Slee A; Saad M; Saksena S
    J Interv Card Electrophysiol; 2019 Sep; 55(3):325-331. PubMed ID: 30887281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the Usefulness of Catheter Ablation of Atrial Fibrillation in Patients With Heart Failure With Preserved Ejection Fraction.
    Aldaas OM; Lupercio F; Darden D; Mylavarapu PS; Malladi CL; Han FT; Hoffmayer KS; Krummen D; Ho G; Raissi F; Birgersdotter-Green U; Feld GK; Hsu JC
    Am J Cardiol; 2021 Mar; 142():66-73. PubMed ID: 33290688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation is an independent risk factor for heart failure hospitalization in heart failure with preserved ejection fraction.
    Yang E; Vaishnav J; Song E; Lee J; Schulman S; Calkins H; Berger R; Russell SD; Sharma K
    ESC Heart Fail; 2022 Oct; 9(5):2918-2927. PubMed ID: 35712815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Atrial Tachyarrhythmia Recurrence on the Development of Long-Term Adverse Clinical Events Following Catheter Ablation in Patients With Atrial Fibrillation With Systolic Impairment: A Single-Center Observational Study.
    Ishiguchi H; Yoshiga Y; Shimizu A; Ueyama T; Ono M; Fukuda M; Kato T; Fujii S; Hisaoka M; Uchida T; Omuro T; Shimokawa M; Okamura T; Kobayashi S; Yano M
    J Am Heart Assoc; 2022 Feb; 11(4):e023640. PubMed ID: 35112883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.